Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted Pulse … news release. “We believe [186Re obisbemeda’s] ability to deliver high-dose …
FDA Grants Orphan Drug Designation for Rhenium (186Re) Obisbemeda in Pediatric Brain Cancer
Share This Story, Choose Your Platform!
About the Author: AJDesign77
